Information:
Error:
ID
39095
Description
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01869764
Link
https://clinicaltrials.gov/show/NCT01869764
Keywords
Versions (1)
- 12/1/19 12/1/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
December 1, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Ductal Breast Carcinoma in Situ NCT01869764
Eligibility Ductal Breast Carcinoma in Situ NCT01869764
- StudyEvent: Eligibility
Similar models
Eligibility Ductal Breast Carcinoma in Situ NCT01869764
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Breast Carcinoma TNM Breast tumor staging | Carcinoma in Situ TNM Breast tumor staging | LCIS TNM Breast tumor staging | DCIS TNM Breast tumor staging
Item
newly diagnosed stage i to iii breast cancer and carcinoma in situ (including lobular carcinoma in situ [lcis] and ductal carcinoma in situ [dcis])
boolean
C0678222 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0007099 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
C0279563 (UMLS CUI [3,1])
C0474926 (UMLS CUI [3,2])
C0007124 (UMLS CUI [4,1])
C0474926 (UMLS CUI [4,2])
C0474926 (UMLS CUI [1,2])
C0007099 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
C0279563 (UMLS CUI [3,1])
C0474926 (UMLS CUI [3,2])
C0007124 (UMLS CUI [4,1])
C0474926 (UMLS CUI [4,2])
Operation on breast Planned | Segmental Mastectomy Planned | Mastectomy Planned
Item
breast surgery (lumpectomy or mastectomy) is planned for at least 7 days from the day of enrollment
boolean
C3714726 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0024885 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C0024881 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
C1301732 (UMLS CUI [1,2])
C0024885 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C0024881 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
Informed Consent
Item
ability to understand and the willingness to sign an institutional review board (irb)-approved written informed consent document
boolean
C0021430 (UMLS CUI [1])
Tumor size Imaging | Tumor size Physical Examination
Item
tumor measures at least 1 centimeter on imaging or physical exam
boolean
C0475440 (UMLS CUI [1,1])
C0011923 (UMLS CUI [1,2])
C0475440 (UMLS CUI [2,1])
C0031809 (UMLS CUI [2,2])
C0011923 (UMLS CUI [1,2])
C0475440 (UMLS CUI [2,1])
C0031809 (UMLS CUI [2,2])
Patient scheduled for surgery | Status post Biopsy
Item
any patient with surgery scheduled < 7days after biopsy
boolean
C3242215 (UMLS CUI [1])
C0231290 (UMLS CUI [2,1])
C0005558 (UMLS CUI [2,2])
C0231290 (UMLS CUI [2,1])
C0005558 (UMLS CUI [2,2])
Discontinue NSAIDs Unable | Discontinue Aspirin Unable
Item
patients who are unable to refrain from the use of any nsaid or full-dose acetylsalicylic acid (asa)-containing nsaid while taking study drug
boolean
C1444662 (UMLS CUI [1,1])
C0003211 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C1444662 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C0003211 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C1444662 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Neoadjuvant Chemotherapy
Item
patients who will receive neoadjuvant chemotherapy are not eligible
boolean
C0600558 (UMLS CUI [1,1])
C3665472 (UMLS CUI [1,2])
C3665472 (UMLS CUI [1,2])
Omega-3 Fatty Acids
Item
patients who are currently taking omega-3 fatty acids, as they are unable to be randomized to placebo
boolean
C0015689 (UMLS CUI [1])
Omega-3 Fatty Acids Previous
Item
patients who have previously taken omega-3 fatty acid within 1 month prior to study enrollment
boolean
C0015689 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,2])
Allergy to fish
Item
patients with an allergy or known hypersensitivity to fish
boolean
C0856904 (UMLS CUI [1])